DMIIUDrugs Made In America Acquisition II Corp.
10.12USD-0.34%Mkt Cap: P/E:

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other si…

Indicators:|

Key Statistics

Company
Market Cap
Enterprise Value644.75M USD
Revenue (TTM)
Gross Profit
Net Income (TTM)4.19M USD
Revenue/Share
Last Price10.12 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees
CountryUS
SectorFinancial Services
IndustryShell Companies
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B-36.14
EPS (TTM)
EPS (Forward)
52W Range
9.93521% of range10.80
52W High10.80 USD
52W Low9.935 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE0.86%
ROA0.83%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-1.02M USD
CapEx (TTM)
FCF Margin
FCF Yield
Net Debt102.28K USD
Net Debt/EBITDA
Balance Sheet
Debt/Equity
Current Ratio0.53
Quick Ratio0.52
Book Value/Sh-0.2800 USD
Cash/Share0.0050 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.
Float50.26M
Insiders1.07%
Institutions6.84%
Short Interest
Short Ratio0.1d
Shares Short132
Short (prev mo.)131
Technical
SMA 5010.09 (+0.3%)
SMA 20010.05 (+0.7%)
Beta
S&P 52W Chg23.71%
Avg Vol (30d)1.97K
Avg Vol (10d)1.50K
Technical Indicators
RSI (14)61.3
MACD0.0227
MACD Signal0.0179
MACD Hist.+0.0049
BB Upper10.17 USD
BB Middle10.09 USD
BB Lower10.02 USD
BB Width1.52%
ATR (14)0.0126 USD
Vol Ratio (20d)1.37x